The mandibular gland secretions and ovarial development of worker honeybees (Apis Mellifera) in the Eastern Cape Province of South Africa

The Eastern Cape is an area in which Apis mellifera capensis, A. m. scutellata and their hybrid are known to naturally occur. I investigated the mandibular gland profiles and ovarial development of queenright workers from 4 localities. Their queens were then removed to determine how these aspects changed upon queen loss. In addition, drifted bees were analysed in the same way to determine how these factors changed once they had gained entry to a foreign hive. The queenright bees, form all 4 localities were found to have 9HDA as the most abundant of the 5 fatty acids measured and all localities had small percentages of 9ODA in their mandibular gland secretions. This resulted in relatively high queenright 9ODA:10HDA and 9HDA:10HDAA ratios. Despite this the percentage of bees with undeveloped ovaries was consistent with their queenright status. The mean values of these 2 ratios were significantly higher in the bees from East London and Cradock than those from Port Elizabeth. Steynsburg's bees were intermediate in this regard. Upon queen loss, the bees from all 4 localities had an increase in the percentage of 9ODA but the other compound changes in varying ways. East London's bees were the only ones not to become significantly more queen-like after queen loss. After 14 days without a queen, the mean values of these 2 ratios were much higher in the bees from Port Elizabeth than those from the other localities. Certain individuals from Port Elizabeth had values of these ratios that exceeded those found in A. m. capensis queens. Port Elizabeth was the only locality to display any surrogate queens and exhibited the highest increase in the number of bees with partially or fully developed ovaries. While certain individuals from the other localities had values of these ratios that exceeded these values reported in A. m. scutellata queens, Steynsburg's bees were the only ones that did increase in in terms of the number of bees with developed ovaries subsequent. The bees from Steynsburg were shown to suppress the mandibular gland and ovarial development of drifters from Port Elizabeth while bees from East London did not

Social parasitism by honeybee workers (Apis mellifera capensis Escholtz): host finding and resistance of hybrid host colonies

We studied possible host finding and resistance mechanisms of host colonies in the context of social parasitism by Cape honeybee (Apis mellifera capensis) workers. Workers often join neighboring colonies by drifting, but long-range drifting (dispersal) to colonies far away from the maternal nests also rarely occurs. We tested the impact of queenstate and taxon of mother and host colonies on drifting and dispersing of workers and on the hosting of these workers in A. m. capensis, A. m. scutellata, and their natural hybrids. Workers were paint-marked according to colony and reintroduced into their queenright or queenless mother colonies. After 10 days, 579 out of 12,034 labeled workers were recaptured in foreign colonies. We found that drifting and dispersing represent different behaviors, which were differently affected by taxon and queenstate of both mother and host colonies. Hybrid workers drifted more often than A. m. capensis and A. m. scutellata. However, A. m. capensis workers dispersed more often than A. m. scutellata and the hybrids combined, and A. m. scutellata workers also dispersed more frequently than the hybrids. Dispersers from queenright A. m. capensis colonies were more often found in queenless host colonies and vice versa, indicating active host searching and/or a queenstate-discriminating guarding mechanism. Our data show that A. m. capensis workers disperse significantly more often than other races of A. mellifera, suggesting that dispersing represents a host finding mechanism. The lack of dispersal in hybrids and different hosting mechanisms of foreign workers by hybrid colonies may also be responsible for the stability of the natural hybrid zone between A. m. capensis and A. m. scutellata

Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570

Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19

International audienc